Effective use of a limited antiviral stockpile for pandemic influenza

Journal of Bioethical Inquiry

Volumn 6, Issue 2, 2009, Pages 171-179

  Arinaminpathy, Nimalan ^a   Savulescu, J ^b   Mclean, Angela R ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

Antiviral drugs; Pandemic influenza; Public health

Indexed keywords

EID: 70349843829     PISSN: 11767529     EISSN: 18724353     Source Type: Journal    
DOI: 10.1007/s11673-009-9164-3     Document Type: Article

References (18)

1. Anderson, R.M. and R.M. May. 1992. Infectious diseases of humans: dynamics and control. Oxford: Oxford University Press.
2. Arinaminpathy, N. and A.R. McLean. 2008. Antiviral treatment for the control of pandemic influenza: some logistical constraints. Journal of the Royal Society, Interface 5(22): 545-553. doi:10.1098/rsif.2007.1152.
3. Australian Department of Health and Ageing. 2006. The Australian health management plan for pandemic influenza. http://www.health.gov.au/internet/main/publishing.nsf/content/phd-pandemic-plan.htm (accessed 8 May 2009).
4. Centers for Disease Control and Prevention. 2003. Human cases of Avian Influenza A (H7N7) infection - The Netherlands, 2003. http://www.cdc.gov/flu/avian/h7n7-netherlands.htm (accessed 8 May 2009).
5. Fan, E.X. and the Asian Development Bank. 2003. SARS: Economic impacts and implications. Singapore: ADB.
6. Johnson, N.P.A.S. and J. Müller. 2002. Updating the accounts: global mortality of the 1918-1920 Spanish influenza pandemic. Bulletin of the History of Medicine 76: 105-115. doi:10.1353/bhm.2002.0022.
7. Jordan, E.O. 1927. Epidemic influenza: A survey. Chicago: American Medical Association.
8. Kilbourne, E.D. 2006. Influenza pandemics of the 20th century. Emerg.Infect.Dis.http://www.cdc.gov/ncidod/EID/vol12no01/05-1254.htm (accessed 8 May 2009).
9. McGeer, A., et al. 2005. Clinical features of laboratory confirmed influenza illness requiring hospital admission in Ontario, Canada: Implications for treatment recommendations. Presented at the 2005 European Scientific Working Group on Influenza (ESWI) congress, Malta. See also Commentary in Roche investor update, http://www.roche.com/inv-update-2005-09-13b.
10. Rawls, J. 1971. A theory of justice. Harvard: Harvard University Press.
11. Taubenberger, J.K., D.M. Morens, and A.S. Fauci. 2007. The next influenza pandemic: Can it be predicted? Journal of the American Medical Association 297: 2025-2027. doi:10.1001/jama.297.18.2025.
12. UK Department of Health. 2007. Pandemic flu: a national framework for responding to an influenza pandemic. http://www.dh.gov.uk/en/Publicationsandstatistics/Publications/PublicationsPolicyAndGuidance/dh_080734 (accessed 8 May 2009).
13. U.S. Department of Health and Human Sevices. 2005. HHS strategic plan, appendix D. http://www.hhs.gov/pandemicflu/plan/#overview (accessed 8 May 2009).
14. Ward, P., I. Small, J. Smith, P. Suter, and R. Dutkowski. 2005. Oseltamivir (Tamiflu) and its potential for use in the event of an influenza pandemic. The Journal of Antimicrobial Chemotherapy 55(Suppl 1): i5-i21. doi:10.1093/jac/dki018.
15. Wan, H., et al. 2008. Replication and transmission of H9N2 influenza viruses in ferrets: Evaluation of pandemic potential. PLoS ONE 3(8): e2923. doi:10.1371/journal.pone.0002923.
16. Webby, R.J. and R.G. Webster. 2003. Are we ready for pandemic influenza? Science 302: 1519-1522. doi:10.1126/science.1090350.
17. World Health Organisation. 2007. Clinical management of human infection with avian influenza A (H5N1) virus. http://www.who.int/csr/disease/avian_influenza/guidelines/ClinicalManagement07.pdf (accessed 8 May 2009).
18. World Health Organisation. 2008. H5N1 Avian influenza: timeline of major events. http://www.who.int/csr/disease/avian_influenza/ai_timeline/en/index.html (accessed 8 May 2009).